The Cornell Case Raises An Overlooked Health Question

Sexual assault can affect physical and mental health for months or years. Here’s what survivors may face—and what good healthcare should provide.

U.K.’s Pharmacy First Program Sidesteps Larger Problem Of NHS Underfunding

While Pharmacy First could partially relieve wait times at GP offices and emergency rooms, it’s sidestepping the larger chronic problem of NHS underfunding.

Drug Makers React To Most-Favored Nation And IRA Pricing Policies

The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.

Drug Makers React To Most-Favored-Nation And IRA Pricing Policies

The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.

Building Resilience Into The Future Of Breast Cancer Care

As Breast Cancer Awareness Month begins, women diagnosed today benefit from decades of progress in care. However, innovation does not automatically create health equity.

Reengineering Blood Clotting With Bispecific Antibodies

Emicizumab, a bispecific antibody that bridges clotting factors IX and X, restores factor VIII function and prevents bleeding in hemophilia A with infrequent injections.

What Do AI Risk, Data Centers And Bananas Have In Common?

AI risk isn’t only about models. Data center concentration and shared digital infrastructure can increase the blast radius when systems fail.

Only 1 In 9 Black Adults Wears Sunscreen. Half Marathon Training Taught Me That’s Only Part Of The Problem

Training for a half marathon? Learn why sunscreen for Black skin matters, plus how to prevent the chafing and dark spots that come with long runs.

Mostly, Health Insurers Maintain Medicare Advantage Markets For 2027

Health insurers in privatized Medicare Advantage are for the most part maintaining their 2027 geographic footprints after a multi-year period of retrenchment.

This Former OpenAI Exec Is Trying To Cure Chronic Diseases, Including Her Own

Sufferers of complex, chronic diseases like POTS and long COVID often spend years searching for relief. The longtime tech exec started ChronicleBio to find treatments using AI and lots of biological data.